bullish

Eris Lifesciences - In Line 4QFY22 at the Operational Level; Geared up for Launches in FY23

197 Views09 May 2022 11:21
Broker
ERIS delivered an operationally inline 4QFY22. It ended the second consecutive year with earnings growth in the a healthy teens compared to stable earnings over FY18-20.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 24-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Motilal Oswal
External broker reports(aggregated public sources)
Motilal Oswal Financial Services Limited
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Eris Lifesciences - In Line 4QFY22 at the Operational Level; Geared up for Launches in FY23
    09 May 2022
x